Literature DB >> 7398184

Sedative and cardiovascular effects of clonidine and nitrazepam.

V Hossmann, T J Maling, C A Hamilton, J L Reid, C T Dollery.   

Abstract

Five healthy male subjects, aged 26 to 35 yr, received single oral doses of clonidine 0.3 mg, nitrazepam 20 mg, or placebo double-blind with an interval of at least 1 wk between each treatment. Clonodine induced a maximal fall in systo9lic blood pressure from 104.2 +/- 1.6 to 84.7 +/- 1.4 mm Hg (mean +/- SEM) after 3.5 hr and nitrazepam from 102.9 +/- 1.9 to 90.3 +/- 2.6 mm Hg after 1.0 hr while after placebo blood pressure rose steadily from 102.5 +/- 2.9 to 109.6 +/- 3.5 mm Hg at the end of the 8-hr study. Total sleep time increased from 90.3 +/- 2.5. min after placebo to 256.2 +/0 21.0 min after clonidine (p < 0.001) and 281.0 +/- 40.3 min after nitrazepam (p < 0.001). Stage I sleep increased from 49.7 +/- 11.2 to 76.9 +/- 10.2 min after clonidine and to 76.3 +/- 25.2 min after nitrazepam (p < 0.0), while the greatest increase was observed in stage II: 230.7 +/- 25.6 min after clonidine and 236.6 +/- 35.4 min after nitrazepam compared with only 48.5 +/- 15.8 min after placebo (p < 0.001). Plasma norepinephrine did not change after placebo but fell after nitrazepam from 0.28 +/- 0.04 to 0.14 +/- 0.02 ng/ml after 3 hr (p < 0.05) and after clonidine from 0.23 +/- 0.07 to 0.07 +/- 0.02 ng/ml after 2 hr (p < 0.01). Clonidine and nitrazepam both induced similar hypnotic and hypotensive effects with some evidence that this might be due to a reduction in sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398184     DOI: 10.1038/clpt.1980.146

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  17 in total

1.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil.

Authors:  D M Ball; P Glue; S Wilson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension.

Authors:  J S Kooner; W S Peart; C J Mathias
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

4.  Human orthostatic reflexes after taking temazepam at night.

Authors:  J M Patrick; M B Dikshit; I A Macdonald; P H Fentem
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  A clinician looks at the future.

Authors:  C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

6.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  MHPG excretion in endogenous depression: relationship to clinical state and the effects of ECT.

Authors:  M H Joseph; D Risby; T J Crow; J F Deakin; E C Johnstone; P Lawler
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Effects of oral chlordemethyldiazepam on plasma adrenaline and noradrenaline and cardiovascular reactivity in preoperative patients.

Authors:  G B Picotti; O Corli; M D Galva; G P Bondiolotti; M O Carruba
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.

Authors:  A D Struthers; M J Brown; E F Adams; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.